About Us
Stroke
Our Product
Partners & Investors
News & Media
Contact

Understanding stroke

Nothing to display, yet.

Understanding stroke

Stroke in brief
Stroke outcomes
Stroke treatment
A new target — GPVI

July 23, 2021

Acticor Biotech Announces the Completion of Enrollment in its GARDEN clinical trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study

Paris, July 22, 2021 – Acticor Biotech, a clinical stage biotechnology company developing an innovative drug for the acute phase of ischemic stroke and thrombotic diseases, today announces the completion of recruitment in GARDEN, its phase 2 clinical study on the use of glenzocimab, a novel humanized monoclonal antibody fragment, in patients with COVID-19- induced […]

Main navigation

About Us
Stroke
Our product
Press Releases
Media Coverage
Publications
Investors

Contact

Contact Us
Follow us on Twitter
Follow us on LinkedIn
Careers

Acticor Biotech
Bâtiment Inserm U1148
Hôpital Bichat, Secteur Claude Bernard
46 rue Henri Huchard
75877 Paris Cedex 18